Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bernardino Alcázar-Navarrete, Francisco García-Rio, Guadalupe Sánchez, Esther Mariscal, Andrea García, Maribel Cuesta, Estefany Uría & Marc Miravitlles. (2021) Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2149-2161.
Read now
Read now
Margarethe E Wacker, Katharina Kitzing, Rudolf A Jörres, Reiner Leidl, Holger Schulz, Stefan Karrasch, Annika Karch, Armin Koch, Claus F Vogelmeier & Rolf Holle. (2017) The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3437-3448.
Read now
Read now
Marc Miravitlles, Juan B Gáldiz, Alicia Huerta, Alba Villacampa, David Carcedo & Francisco Garcia-Rio. (2016) Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 123-132.
Read now
Read now
Articles from other publishers (7)
Joshua Taylor, Mayara Lisboa Bastos, Sophie Lachapelle-Chisholm, Nancy E. Mayo, James Johnston & Dick Menzies. (2023) Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis. eClinicalMedicine 59, pages 101979.
Crossref
Crossref
Cristina Esquinas, Maria A. Ramon, Alexa Nuñez, Jesús Molina, José A. Quintano, Miguel Roman-Rodríguez, Karlos Naberan, Carl Llor, Carlos Roncero, Marc Miravitlles & Miriam Barrecheguren. (2019) Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Quality of Life Research 29:3, pages 607-617.
Crossref
Crossref
Kelsey Maass & Minsun Kim. (2020) A Markov decision process approach to optimizing cancer therapy using multiple modalities. Mathematical Medicine and Biology: A Journal of the IMA 37:1, pages 22-39.
Crossref
Crossref
María Merino, Renata Villoro, Álvaro Hidalgo-Vega & Concepción Carmona. (2019) Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study. Health and Quality of Life Outcomes 17:1.
Crossref
Crossref
Екатерина Кулик, Ekaterina Kulik, Валентина Павленко, Valentina Pavlenko, Светлана Нарышкина & Svetlana Naryshkina. (2019) PREDICTING THE EFFECTIVENESS OF TREATMENT WITH ROFLUMILAST IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Bulletin physiology and pathology of respiration 1:71, pages 51-56.
Crossref
Crossref
Wouter Poortinga, Sarah E Rodgers, Ronan A Lyons, Pippa Anderson, Chris Tweed, Charlotte Grey, Shiyu Jiang, Rhodri Johnson, Alan Watkins & Thomas G Winfield. (2018) The health impacts of energy performance investments in low-income areas: a mixed-methods approach. Public Health Research 6:5, pages 1-182.
Crossref
Crossref
Margarethe E. Wacker, Rudolf A. Jörres, Annika Karch, Armin Koch, Joachim Heinrich, Stefan Karrasch, Holger Schulz, Annette Peters, Sven Gläser, Ralf Ewert, Sebastian E. Baumeister, Claus Vogelmeier, Reiner Leidl & Rolf Holle. (2016) Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies. Respiratory Research 17:1.
Crossref
Crossref